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Mitochondria are principal regulators of cellular function and metabolism through production of ATP for
energy homeostasis, maintenance of calcium homeostasis, regulation of apoptosis and fatty acid oxidation to
provide acetyl CoA for fueling the electron transport chain. In addition, mitochondria play a key role in cell
signaling through production of reactive oxygen species that modulate redox signaling. Recent ﬁndings support
an additional mechanism for control of cellular and tissue function by mitochondria through complex
mitochondrial–nuclear communication mechanisms and potentially through extracellular release of mitochon-
drial components that can act as signaling molecules. The activation of stress responses including mitophagy,
mitochondrial number, ﬁssion and fusion events, and the mitochondrial unfolded protein response (UPRMT)
requires mitochondrial–nuclear communication for the transcriptional activation of nuclear genes involved in
mitochondrial quality control and metabolism. The induction of these signaling pathways is a shared feature in
long-lived organisms spanning from yeast to mice. As a result, the role of mitochondrial stress signaling in
longevity has been expansively studied. Current and exciting studies provide evidence that mitochondria can
also signal among tissues to up-regulate cytoprotective activities to promote healthy aging. Alternatively,
mitochondria release signals to modulate innate immunity and systemic inﬂammatory responses and could
consequently promote inﬂammation during aging. In this review, established and emerging models of
mitochondrial stress response pathways and their potential role in modulating longevity are discussed.
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The concept that mitochondrial function declines during aging has
been a basic tenet of the biology of aging for many years. Paradoxi-
cally, it has been shown, ﬁrst in yeast and later in mice, that
perturbations of some mitochondrial electron transport chain (ETC)
complexes increase lifespan [1–3]. These results are counterintuitive,
yet they have the potential to signiﬁcantly shift the way we think
about the role of mitochondrial function in general and especially in
aging. Recent studies have provided evidence to support the hypoth-
esis that up-regulation of mitochondrial stress responses contributes
to enhanced longevity in the long-lived mitochondrial mutants [3–5].
These stress responses include mitochondrial turnover, ﬁssion and
fusion events, regulation of mitochondrial number (induction of
mitochondrial biogenesis), retrograde signaling, and themitochondrial
unfolded protein response UPRMT. Compromised mitochondrial stress
responses could contribute to age-related accumulation of damaged
proteins, reduced oxidative phosphorylation, increased reactive oxy-
gen species production, and induction of cellular apoptosis. As a result,
maintenance of mitochondrial stress responses has gained recognition
as a potential pro-longevity mechanism in the aging ﬁeld. Under-
standing the molecular mechanisms by which mitochondrial stress
responses might lead to longevity is key for the development of
interventions to prevent age-associated diseases and improve health-
span. Here, we review recent studies that have shed light on the
relationship between mitochondrial stress signaling and longevity.Yeast retrograde response
Retrograde signaling in yeast is a mitochondrial-to-nuclear
signal transduction pathway resulting in the induction of nucle-
ar-encoded mitochondrial genes in response to mitochondrialFig. 1. Yeast retrograde response. Under normal conditions, ATP competitively binds to
allowing Mks-1 to bind to the 14-3-3 protein Bmh1/2, another negative regulator of th
Rtg2 has also been shown to suppress the formation of extrachromosomal rDNA cir
mitochondrial stress, Rtg2 is stabilized by Mks1. Stabilized Rtg2 promotes the dephospho
turns on the transcription of retrograde genes. Rtg2 can also modulate the retrograde res
As a result, cell survival is promoted.stress (see Fig. 1). Ron Butow discovered the yeast retrograde
response in 1987 [6]. Butow showed that yeast lacking mitochon-
drial DNA (rho° cells) modulate the transcript levels of nuclear-
encoded mitochondrial genes [6]. A genome-wide analysis of rho°
cells and yeast treated with mitochondrial electron transport chain
(ETC) inhibitors demonstrated alterations in a wide-range of
nuclear-encoded genes [7]. The majority of the genes up-regulated
encode for proteins that facilitate a metabolic switch from aerobic
to anaerobic respiration [8].
A number of studies have deﬁned the molecular pathways
involved in the retrograde response [9–11]. Defective mitochon-
dria release a retrograde signal to activate the nuclear-localization
of the Rtg1/3 complex that consists of two basic helix–loop–helix
leucine zipper transcription factors [11]. This complex regulates
the expression of genes encoding for enzymes in mitochondrial
metabolism, peroxisomal biogenesis and stress response pathways
[8,12]. The activation of the Rtg1/3 complex is dependent on the
phosphorylation of Rtg3 [11]. A cytoplasmic protein, Rtg2 pro-
motes the partial dephosphorylation of Rtg3 through an interac-
tion with Mks-1, a negative regulator of the retrograde response
[11,13]. ATP competitively binds to Mks-1 releasing Rtg2 and
allowing Mks-1 to bind to the 14-3-3 protein Bmh1/2, which
inhibits the translocation of the Rtg1/3 complex [10,14]. Therefore,
low levels of ATP promote the interaction between Rtg2 and Mks-
1 and activation of the retrograde response. The exact mechanism
of Rtg3 dephosphorylation is currently not known.
Regulation of the retrograde response
More recent work has investigated the mitochondrial signal
that triggers the retrograde response. One potential signal is
mitochondrial membrane potential. Loss of membrane potential
was shown to trigger the retrograde response in rho° and cox4 nullMks1, a negative regulator of the retrograde response (RTG), releasing Rtg2 and
e RTG. Consequently, this inhibits the nuclear translocation of the Rtg1/3 complex.
cles (ERCs). Under conditions of reduced mitochondrial membrane potential or
rylation of Rtg3. Subsequently, Rtg1/3 complex translocates to the nucleus where is
ponse by interacting with the transcriptional co-activator SAGA-like (SLIK) complex.
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induction of the retrograde response [15]. To date, it is not known
how Rtg2 senses the loss of membrane potential to modulate the
translocation of the Rtg1/3 complex. The production of reactive
oxygen species (ROS) is an unlikely candidate for the retrograde
signal as supplementing rho° cells with a free radical quencher
does not reverse the retrograde response [15]. Rho° strains
effectively use glycolysis to compensate for reduced oxidative
phosphorylation, and ATP concentrations are relatively unchanged
compared to wild-type yeast. Therefore, it is unlikely that reduced
ATP levels serve as a retrograde signal. However, the impact of ATP
levels cannot be completely ruled out as a recent study revealed
that the interaction between Mks-1 and Rtg2 are dependent on
physiological ATP levels [14].
Rtg2 has also been shown to modulate the retrograde response
by interacting with the transcriptional co-activator SAGA-like
(SLIK) complex, a conserved histone acetyltransferase-coactivator
of gene expression [16]. Rtg2 is a component of SLIK and is present
at the promoter of retrograde genes [16]. Deletion of a critical
component of the SLIK complex, GCN5, suppresses the retrograde
response in rho° cells [17]. Recently, the retrograde response has
also been linked to TOR signaling. Lst8p, a component of the target
of rapamycin complex I (TORC1), negatively regulates the retro-
grade response both upstream and downstream of Rtg2 [10,18]. In
addition, inhibition of TORC1, via rapamycin, induces the expres-
sion of retrograde genes [18]. However, induction of the retrograde
response by mitochondrial dysfunction does not require TOR.
Rather, it is speculated that TOR regulates the retrograde response
through sensing nutrient availability [18].
Retrograde response and longevity
The relationship between the retrograde response and long-
evity was ﬁrst implicated in a long-lived rho° yeast strain.
Speciﬁcally, deletion of Rtg2 was shown to reverse replicative
lifespan extension in rho° cells [5]. Conversely, replacing mtDNA in
rho° cells with intact mtDNA through cytoduction abrogates the
retrograde response and reverses lifespan extension [5]. Reduced
respiratory capacity is not responsible for lifespan extension since
treatment with mitochondrial ETC, inhibitors does not alter life-
span in wild-type yeast, and other respiratory deﬁcient yeast that
exhibit basal retrograde signaling do not have increased lifespan
[5]. This was conﬁrmed by another study showing that rho°
longevity is not due to reduced oxidative capacity since nuclear
petite mutants of the same yeast background did not extend
lifespan compared to wild-type control [19]. Furthermore, in-
creased reactive oxygen species production does not appear to
be responsible for lifespan extension associated with retrograde
signaling because overexpression of antioxidant enzymes does not
suppress lifespan extension in rho° cells [5]. Retrograde response-
mediated lifespan extension is not restricted to replicative life-
span, since it was also shown to mediate chronological lifespan in
yeast [20]. Finally, the retrograde response has also been linked to
stress resistance [21]. For example, yeast cells grown on a non-
fermentable carbon source, rafﬁnose, are resistant to acetic acid
program cell death (AA-PCD) and show induction of the retrograde
response [21].
The metabolic state is critical for initiating the retrograde
response and regulating lifespan in rho° cells. In yeast lacking
RAS2, a critical factor in sensing nutrient availability, the retro-
grade response and longevity is repressed in rho° cells [5]. Caloric
restriction, initiated in yeast by limiting the availability of glucose
or non-essential amino acids, induces citric acid cycle and retro-
grade response genes [22,23]. However, inhibiting the retrograde
response by deletion in the RTG2 or RTG3 genes, does not
suppress lifespan extension-mediated by caloric restriction [22].Thus, caloric restriction mediates longevity independent of the
retrograde response pathway.
Retrograde response and ERCs
A hallmark phenotype of yeast aging is the accumulation of
extrachromosomal rDNA circles (ERCs), which have detrimental
effects on cellular homeostasis [24]. Surprisingly, activation of the
retrograde response is associated with the accumulation of ERCs.
This is consistent with the fact that activation of the retrograde
response increases with age. Rho° cells have a greater accumula-
tion of ERCs compared to wild-type cells partly due to activation of
retrograde response [25]. Eliminating ERCs by deletion of FOB1, a
gene that encodes for a protein required for ERC formation, further
extends rho° cell lifespan by 50% [25]. Rtg2 suppresses ERC
production and disruption of the SLIK complex by GCN5 deletion
lessens the ERC load in rho° cells due to the release of Rtg2 from
the SLIK complex [17]. However, disruption of SLIK suppresses the
retrograde response and lifespan extension of rho° cells [17].
Together, this suggests that lifespan extension in rho° cells is
mediated by retrograde signaling, not by ERC accumulation.
Alternative mitochondrial–nuclear signaling pathways in yeast
A recently discovered mitochondrial–nuclear transduction
pathway, coined mitochondrial back-signaling, was also shown
to mediate longevity [26]. This pathway is activated in response to
a deletion in the AFO1/MRPL25 gene, which encodes for a protein
found in the large subunit of the mitochondrial ribosome. Deletion
of this gene results in a 60% increase in replicative lifespan and
enhanced resistance to oxidative stress [26]. Lifespan extension
and resistance to oxidative stress through this pathway requires an
active target of rapamycin complex 1 (TORC1) and transcription
factor Sfp1, a regulator of cytoplasmic translation. Another mito-
chondrial–nuclear transduction pathway independent of retro-
grade signaling mediates nuclear genomic silencing in a Sir2
histone deacetylase dependent manner [27]. Disruption in the
mitochondrial translation complex activates this pathway and
promotes longevity. These two pathways warrant further investi-
gation, as they will help elucidate mechanisms of pro-longevity.
Retrograde response in mammals
A number of mammalian cell types lacking mitochondrial DNA
were shown to have higher expression levels of genes encoding for
enzymes in glycolysis, mitochondrial and peroxisomal metabo-
lism, lipid transport, inﬂammation and oxidative stress [28,29].
Structural modeling and alignment identiﬁed Myc and Max as
putative mammalian homologs for Rtg1 and Rtg3, respectively
[30]. In mammalian rho° cells, Myc transcript and protein levels
are signiﬁcantly elevated [29]. RNAi knockdown of Myc sup-
pressed the induction of a number of retrograde-related genes in
rho° cells, strongly suggesting that the retrograde response is
evolutionarily conserved [29]. Furthermore, induction of the retro-
grade response via mild uncoupling delays senescence as indi-
cated by increased population doubling [31]. Together, these
results hint that the retrograde response may positively inﬂuence
mammalian aging as was demonstrated in yeast.Mitochondrial unfolded protein response
The mitochondrial unfolded protein response (UPRMT) is a
mitochondrial–to-nuclear signal transduction pathway or retro-
grade response; initiated by the accumulation of unfolded proteins
in the mitochondria and resulting in the induction of speciﬁc
Fig. 2. Mitochondrial unfolded protein response (UPRMT) in C. elegans and mammals. (A) In C. elegans, mis-folded proteins are degraded by the ClpP protease and the cleaved
products are exported to the cytosol through the HAF-1 peptide exporter. These peptides serve as a signal for activation of transcription factor, ATFS-1. Subsequently, ATFS-1
activates Ubl-5 to form a complex with transcription factor Dve-1 to transcriptionally activate UPRMT genes. (B) Currently, the signaling pathways involved in the UPRMT in
response to mitochondrial protein stress are not completely deﬁned in mammals. The accumulation of mis-folded proteins has been shown to activate the UPRMT through
the Jnk/c-Jun pathway. In response to mis-folded proteins, protein kinase R (PKR) is activated and activates the nuclear translocation of Jnk via phosphorylation, which
activates the transcription factor, c-Jun. Activated c-Jun in turn binds to the activation protein-1 (AP-1) element to initiate the transcription of CHOP. Subsequently, CHOP and
co-transcriptional activator, C/EBPβ, induce the expression of UPRMT genes. Interestingly, activation of the Jnk/c-Jun pathway requires the ClpP protease suggesting that
cleaved peptides could potentially serve as an initial signal for the induction of the UPRMT.
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proposed in Caenorhabditis elegans in which mitochondrial stress
involving unfolded proteins was shown to up-regulate the ATP-
dependent mitochondrial matrix ClpP protease, a protease that
cleaves mis-folded proteins (see Fig. 2) [32,34]. The cleaved
proteins (peptides) are exported out from the mitochondria to
the cytosol through the mitochondrial matrix peptide exporter
HAF-1 [35]. The exported peptides serve as a signal for the
activation of the bZip transcription factor ATFS-1. ATFS-1 has a
mitochondrial targeting sequence and nuclear localization se-
quence. Under basal conditions, ATFS-1 is imported into the
mitochondria and degraded by the Lon protease in the mitochon-
drial matrix; however, when mitochondria are stressed, ATFS-1
accumulates in the cytosol [35]. This accumulation leads to the
trafﬁcking of ATFS-1 to the nucleus. ATFS-1 activates UBL-5 to
form a complex with the transcription factor DVE-1 to transcrip-
tionally activate mitochondrial chaperones such as heat shock
protein 6 (Hsp6) and Hsp 10 [34–36]. Furthermore, microarray
analysis in C. elegans revealed that the UPRMT also induces the
transcription of coenzyme Q biosynthesis, mitochondrial ﬁssion,
glycolysis, and biogenesis genes [36–38]. These ﬁndings suggest
that the UPRMT alters mitochondrial metabolism to promote
mitochondrial function and cell survival during stress. Recent
studies have shown that the UPRMT can be activated in response
to mitochondrial stress, including depletion of the mitochondrial
genome [39], deletions in mitochondrial ETC genes [3], inhibition
of mitochondrial protease activity [36,37], and reagents that
induce reactive oxygen species production [39].The UPRMT has not been studied extensively in mammals, but
UPRMT components are elevated in mitochondrial DNA depleted
mammalian cells, suggesting a conserved signaling mechanism in
response to mitochondrial stress [33,40]. Two potential mamma-
lian orthologues of transcription factors involved in the response
in C. elegans include SATB1, an orthologue for DVE-1, which is a
CREB-binding protein (CBP) partner [41] and UBL-5 [42]. However,
to date no studies have shown the involvement of these transcrip-
tion factors in the transcriptional control of mitochondrial stress
proteins in mammals. The conserved regulatory element in pro-
moters of the UPRMT related genes (e.g., Hsp60, Hsp10, mtDnaJ,
ClpP, YME1L1, PMPCB, TIMM17A, NDUFB2, Trx2 and endoG)
implicate the transcription factors CHOP and C/EBPβ as putative
transcription factors for this pathway [37]. Transcriptional activa-
tion of the CHOP gene is regulated by the UPRMT through AP-1
(activation protein-1) element [43]. Transcriptional activation of
CHOP is under the control of the Jnk/c-Jun pathway. There is
evidence that transcriptional factor, c-Jun binds to the AP-1
element of CHOP suggesting that the transcriptional activation of
CHOP is under the control of the Jnk/c-Jun pathway [44,45].
Consistent with this, Cos-7 cells with increased UPRMT activity
induced by a mutation in mitochondrial ornithine transcarbam-
lyase (OTC) have elevated levels of phosphorylated-Jnk [46]. The
induction of the UPRMT triggered by an OTC mutation, is depen-
dent on protein kinase R (PKR) and PKR activity is required for the
activation of c-Jun and transcriptional activation of CHOP [46].
Furthermore, PKR activation requires ClpP protease, suggesting a
potential involvement of mitochondrial peptide release for UPRMT
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Together these data predict one putative signaling pathway
involved in the mammalian UPRMT, but leave many unanswered
questions.
The UPRMT and longevity
A link between UPRMT and longevity was ﬁrst revealed in two
long-lived C. elegans mitochondrial mutants (isp-1 and clk-1) [3].
RNAi knockdown of either UBL-5 or DVE-1 reversed lifespan
extension in both isp-1 and clk-1 mutants. Since that ﬁrst study,
there have been a number of other reports implicating the UPRMT
in longevity. For example, a recent study showed that mitochon-
drial biogenesis and components of the UPRMT were up-regulated
in the previously reported long-lived Complex IV deﬁciency
mouse, Surf1 / [1,4]. Another recent study showed that longer-
lived mice have decreased expression of mitochondrial ribosomal
protein 5 (mrps-5), indicating that reduced mitochondrial transla-
tion correlates with longevity [47]. In fact, RNAi knockdown of
mrps-5 extends lifespan and strongly induces the UPRMT in C.
elegans. Supplementation with the free radical scavenger, N-acet-
ylcysteine, had no effect on lifespan suggesting that longevity is
independent of ROS production [47]. However, lifespan extension
was suppressed with RNAi knockdown of the UPRMT component,
HAF-1.
Studies in C. elegans showed that the inhibition of Complex IV
using RNAi against cco-1 and restricted to neuronal tissue in-
creased lifespan and induced the UPRMT not only in neurons but
also in a heterologous tissue, the intestine [3]. These ﬁndings
suggest that there is not only intracellular signaling resulting in
UPRMT activation, but that there is also signaling between tissues
resulting in UPRMT activation. It is possible that cells in one tissue
may sense stress and induce a nuclear response that would lead to
the extracellular release of a signal, coined mitokine [3], to
generate UPRMT response in a distal tissue. It is not clear whether
cell-nonautonomous induction of the UPRMT is required for
enhanced longevity in the cco-1 worms.
Mitochondrial systemic signaling also exists in Drosophila. In
ﬂies, muscle-speciﬁc disruption of Complex I was shown to
promote healthy longevity and preserve mitochondrial and muscle
function with age [48]. These ﬁndings were dependent on the
induction of the UPRMT since RNAi knockdown of either ClpX and
Hsp60C suppressed climbing performance and lifespan. Not sur-
prisingly, reducing ClpX and Hsp60C expression levels also sup-
pressed climbing performance and lifespan in wild-type ﬂies
suggesting the requirement of the UPRMT for muscle homeostasis
[48]. In contrast to C. elegans, UPRMT induction in Drosophila
appears to require mitochondrial dependent ROS production.
Overexpression of the mitochondrial antioxidant enzymes catalase
and glutathione peroxidase suppressed UPRMT in Complex-1
defective ﬂies [48]. To eliminate other potential mechanisms by
which Complex-1 could mediate longevity, Hsp60 and Hsp60c
were overexpressed in muscle of Drosophila. Muscle-speciﬁc over-
expression of UPRMT chaperones had no effect on lifespan how-
ever, mitochondrial and muscle function were preserved with age
[48]. It is possible that limiting UPRMT in one tissue in Drosophila is
not sufﬁcient to enhance whole organismal lifespan and may
require whole body overexpression. However, despite the lack of
effect on lifespan, muscle-speciﬁc overexpression of UPRMT cha-
perones did result in improved healthspan.
A number of other pro-longevity models, independent of
perturbations of mitochondrial ETC, complexes result in the
induction of the UPRMT. For example, there is a long-standing
association between the sirtuin-1 signaling pathway and long-
evity. Supplementation of NADþ precursors, nicotinamide (NAM)
and NAM ribose (NR), signiﬁcantly induces the UPRMT andantioxidant response in both C. elegans and mammals [49]. In C.
elegans, UPRMT induction is associated with enhanced longevity
and partial protection against age-related decline in mitochondrial
function [49]. Lifespan extension via supplementation of NADþ
precursors or Sir2.1 overexpression is suppressed by RNAi knock-
down of UBL-5. However, it is not clear whether lifespan extension
mediated by NADþ/Sirt1 pathway is singly dependent on UPRMT
induction or also requires an antioxidant response, as UBL-5 was
also shown to regulate the antioxidant response in C. elegans [49].
In addition, the life-extending intervention, rapamycin, is also a
potent inducer of the UPRMT in both C. elegans and mammals [47].
Lifespan extension is suppressed with RNAi knockdown of UBL-5
in C. elegans suggesting that rapamycin-mediated longevity re-
quires the UPRMT. Similar observations were made with resvera-
trol. In these models, it is proposed that the UPRMT activation is
due to an imbalance of mitochondrial to nuclear-encoded proteins
(i.e., mitonuclear imbalance) [47].
The causal relationship between UPRMT and longevity has been
called into question by a recent study showing that the UPRMT is
not necessary for longevity. In previous studies, RNAi used against
HAF-1 and UBL-5 did not fully attenuate the UPRMT in cco-1 and
mrps-5 RNAi treated worms [3,47,49]. In fact, UPRMT induction was
still signiﬁcantly higher when compared to untreated worms.
Furthermore, employing RNAi knockdown of ATFS-1 to inhibit
the UPRMT had no effect on lifespan in the isp-1 mutant or C.
elegans with RNAi knockdown of cco-1, letm-1 and Y24D9A.8
despite a reduction in UPRMT in response to reduced ATFS-1
[50]. In addition, some C. elegans mitochondrial mutants with
increased UPRMT were reported having no change in lifespan or
they were short-lived compared to wild-type control [50]. These
data suggest that UPRMT is not causally linked to longevity nor
does it promote longevity. In support of this, deletion of ClpP, a key
modulator of the UPRMT was shown to result in increased lifespan
in fungi [51]. Thus, these studies highlight the complex relation-
ship between UPRMT in longevity.Mitochondrial-derived peptides, newly discovered modulators
of cytoprotective activities
Mitochondrial-derived peptides (MDPs) are a newly discovered
set of mitochondrial stress signals that are generated within the
mitochondrial genome. Humanin, the ﬁrst discovered MDP, is
released during mitochondrial dysfunction, resulting in an in-
crease of cytoprotective activities and metabolic adaptation [52].
In fact, humanin was discovered using a functional expression
screening for peptides and proteins that could suppress neuronal
cell death caused by multiple types of familial Alzheimer’s disease
[52,53]. There is controversy over whether humanin is of mito-
chondrial or nuclear origin. However, evidence points toward
mitochondrial origin; humanin has 99% sequence similarity to
mitochondrial-encoded 16s RNA, humanin is absent in cells
depleted of the mitochondrial genome, and humanin is formy-
lated, a hallmark post-translation modiﬁcation of mitochondrial-
encoded proteins [54,55]. To date, it is not clear whether humanin
is translated in the mitochondria and then exported to the
cytoplasm or vice versa. Nevertheless, humanin has gained sig-
niﬁcant recognition for its versatile cytoprotective activities.
Humanin has several modes of action. Intracellular humanin
binds to IGFBP-3, Bax, and tBid [53,56,57]. As a result, humanin
suppresses apoptosis and promotes cell survival during stress.
Intracellular levels of humanin are regulated by its interaction
with Trim11, which promote ubiquitin-mediated degradation
[58,59]. Humanin is also present in human plasma, suggesting
that cells secrete humanin. Cells sense circulating humanin
through two plasma membrane receptors, the trimeric CNTFR/
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ber of cytoprotective activities are initiated upon binding to these
receptors. Studies have shown that humanin is neuroprotective,
ameliorates atherosclerotic plaque formation, and is protective in
rodent models of diabetes [62–67]. Humanin was also shown to
restore physiological ATP levels in lymphocytes isolated from
MELAS patients [68]. Together these studies implicate humanin
as a potential therapeutic target for a number of diseases.
Recent studies suggest that MDPs, like humanin, may be a key
pro-longevity factor due to its versatile cytoprotective activities.
Offspring of centenarians have three-fold higher levels of huma-
nin. Rats have a signiﬁcant loss of humanin in brain and skeletal
muscle with age [69]. Conversely, circulating humanin levels
signiﬁcantly decline with age in mice and humans [62,64,69].
Humanin may be one promising intervention for age-related
diseases and to improve healthspan.Mitochondrial-derived damage associated-molecular patterns
For many years, studies have shown that mitochondrial dys-
function is tightly associated to the immune response and inﬂam-
mation [70,71]. Recent work has identiﬁed a number of mitochon-
drial-derived signals that modulate the immune response and
inﬂammation. These signals, also known as mitochondrial damage
associated-molecular patterns (DAMPs), have been shown to be in
the form of mitochondrial DNA (mtDNA), N-formyl peptides and
mitochondrial proteins. Recently mitochondrial dysfunction re-
lated to impaired autophagy was shown to lead to the export of
mtDNA to the cytoplasm activating caspase-1 and promoting the
secretion of IL-1β and IL-18 in macrophages [72]. Degraded
mtDNA has also been shown to strongly induce production ofFig. 3. Signaling factors that mediate mitochondrial crosstalk between cells and tissues.
both intracellularly and extracellularly. (A) For example, humanin, a mitochondrial-deri
mitochondria to suppress apoptosis through binding to IGFBP-3 and pro-apoptotic facto
metabolic-protective properties through its binding to the FPRL1/2 and CNFTR/gp130/W
released by cells to induce the UPRMT in distal cells. (C) Mitochondria can release da
(mitDAMPs), to promote inﬂammation and activate the innate immune response b
inﬂammatory cytokines endogenously and in distal cells.pro-inﬂammatory cytokines in mouse astrocytes [73]. MtDNA is a
ligand for the toll-like receptor 9 (TLR9), which is critical for the
synthesis of pro-inﬂammatory cytokines. Activation of TLR9 can
have signiﬁcant downstream effects on vascular function. In fact,
mtDNA plasma levels are signiﬁcantly elevated in hypertensive
rats [74]. Together these data suggest that mtDNA can serve as an
endogenous and exogenous danger signal to activate an inﬂam-
matory response. Another group of mitDAMPs is N-formyl pep-
tides with mitochondrial origin. These peptides have high afﬁnity
toward Formyl Peptide Receptors (FPR), a class of G-coupled
receptors involved in chemotaxis, a critical action in the inﬂam-
matory response [75]. N-formyl peptides stimulate the expression
of pro-inﬂammatory cytokines, activate innate immune response
and cause systemic inﬂammation and lung injury in rats [76–78].
There are a number of mitochondrial proteins that have been
implicated to serve as mitDAMPs. For example, a recent study
showed that neurons treated with whole mitochondrial protein
extracts had an increased expression of pro-inﬂammatory cyto-
kines and induced cell death [79]. Serum cytochrome c levels are
severely elevated in patients with systemic inﬂammatory response
syndrome and in patients on hemodialysis, a procedure known to
cause inﬂammation [80,81]. Mitochondrial transcription factor A
(TFAM), an implicated mitDAMP, can activate monocytes and
plasmacytoid dendritic cell responses [82,83]. TFAM was shown
to induce the expression of pro-inﬂammatory cytokines for micro-
glial activation, a predecessor of neuronal cell death [79]. In fact,
neurons incubated in conditioned media from TFAM-treated
microglia induced cell death [79].
The discovery of mitDAMPs provides evidence that mitochon-
dria can directly regulate immune response and systemic inﬂam-
mation. These ﬁndings beg the question: do mitDAMPs contribute
to inﬂammaging? It was recently shown that circulating mtDNA isMitochondrial dysfunction can result in the release of signaling factors that can act
ved peptide that is generated within the mitochondrial genome, is released by the
rs, Bax and tBid. Humanin can also exert its cytoprotective, anti-inﬂammatory and
SX-1 receptors. (B) Mitokines are recently hypothesized signaling factors that are
nger signals, also known as mitochondrial damage associated-molecular patterns
oth intracellularly and extracellularly. MitDAMPs induce the expression of pro-
S. Hill, H. Van Remmen / Redox Biology 2 (2014) 936–944942signiﬁcantly elevated in the elderly population [84]. The fact that
mitDAMPs have potent effects on the vascular system suggests
that mitDAMPs could contribute to age-related diseases such as
cardiovascular disease and atherosclerosis. It is also tempting to
speculate that mitDAMPs are one potential contributor to age-
related neurodegeneration since extracellular TFAM can activate
microglia and induce neuronal cell death, common features of
the aging brain [79]. Overall, mitDAMPs have signiﬁcant clinical
relevance and may be a promising target to ameliorate
inﬂammaging.
Concluding remarks/summary
In just the last few years, mitochondrial research has signiﬁ-
cantly evolved, especially in the ﬁeld of aging. Communication
between mitochondria and nucleus is a well-established phenom-
enon that occurs as a result of mitochondrial dysfunction. This
phenomenon is observed in longer-lived species with perturba-
tions in the mitochondrial electron transport chain. Until recently
the signaling pathways that elicit mitochondrial–nuclear commu-
nication were unknown. The discovery of these pathways has
allowed the ﬁeld to closely assess the relationship between
mitochondrial–nuclear signaling and longevity. In the majority of
the studies reviewed here, this relationship has been evaluated by
genetic manipulation of critical components of either the retro-
grade response or UPRMT in long-lived species. In most cases,
knockdown of these components reversed lifespan extension in
long-lived mitochondrial mutants suggesting that these signaling
pathways are essential for longevity. However, recent work pub-
lished by Kaeberlein’s group [50] does not support a causal link
between the UPRMT and longevity. In agreement with these
ﬁndings, overexpression of the UPRMT components Hsp60 and
ClpP does not extend longevity in Drosophila, but does extend
healthy aging. Thus, the UPRMT may not be a viable target to
increase lifespan, but should not be ruled out as a target for the
improvement of age-related diseases. These studies highlight the
complex relationship between longevity and the UPRMT.
An emerging concept in the aging ﬁeld is the idea that
mitochondria can signal between tissues to upregulate cytopro-
tective activities to promote healthy aging and organismal ﬁtness
(see Fig. 3). The discovery of the mitochondrial-derived peptide,
humanin, has unraveled other modes by which mitochondria can
regulate signal transduction pathways. Even more interestingly,
humanin can serve as a cell-nonautonomous signal. In support of
this concept, Dillin’s laboratory found that the UPRMT is activated
in a cell-nonautonomous fashion in C. elegans [3]. Also, there are a
number of reports showing that mitochondria can release a danger
signal, mitDAMP to activate immune response and inﬂammation
in other tissues and organs. Despite the controversy over the
origin of humanin (nuclear or mitochondrial), it is a novel peptide
that has signiﬁcant implications in the development of therapeu-
tics to ameliorate metabolic and age-related diseases. Therefore,
future studies should aim to uncover additional peptides that have
cytoprotective activities similar to humanin.Acknowledgements
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